| http://www.w3.org/ns/prov#value | - King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel brande...Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research...n for Cancer Research (AACR), that reviewed Dream Team applications and made recommendations on funding to SU2C
|
